Association of the Prol2Ala polymorphism in peroxisome proliferator- activated receptor-γ gene with rheumatoid arthritis in Sichuan Province of China

Chinese Journal of Medical Genetics

Volumn 26, Issue 1, 2009, Pages 87-90

  Pan, Xiao Fu ^a   Song, Xing Bo ^a   Wang, Lan Lan ^a   Li, Li Xin ^a   Ying, Bin Wu ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Genetic polymorphism; Peroxisome proliferator activated receptor ; Rheumatoid arthritis

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE;

ALLELE; ARTICLE; CHINA; CLINICAL STUDY; CONTROL GROUP; CONTROLLED STUDY; DATA ANALYSIS; EUROPE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POPULATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; WESTERN HEMISPHERE; ADULT; ASIAN; CASE CONTROL STUDY; ETHNIC GROUP; FEMALE; GENETICS; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA;

EID: 60549105578     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-9406.2009.01.020     Document Type: Article

References (17)

1. Ricote M, Li AC, Willson TM, et al. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature, 1998, 391: 79-82.
2. Yamazaki R, Kusunoki N, Matsuzaki T, et al. Nonsteroidal antiinflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor gamma in rheumatoid synovial cells. J Pharmacol Exp Ther, 2002, 302: 18-25.
3. Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis: a genomewide study. N Engl J Med, 2007, 357: 1199-1209.
4. Deeb SS, Fajas L, Nemoto M, et al. A Prol2Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet, 1998, 20: 284-287.
5. Jiang J, Gajalakshmi V, Wang JW, et al. Influence of the C161T but not Prol2Ala polymorphism in the peroxisome proliferator-activated receptor- gamma on colorectal cancer in an Indian population. Cancer Sci, 2005, 96: 507-512.
6. Paltoo D, Woodson K, Taylor P, et al. Prol2Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene and risk of prostate cancer among men in a large cancer prevention study. Cancer Lett, 2003, 191: 67-74.
7. Berer J, David EM. The mechanisms of action of PPARs. Annu Rev Med, 2002, 53: 409-435.
8. Soller M, Tautenhahn A, Brune B, et al. Peroxisome proliferator-activated receptor (gamma) contributes to T lymphocyte apoptosis during sepsis. J Leukoc Biol, 2006, 79: 235-243.
9. Setoguchi K, Misaki Y, Terauchi Y, et al. Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B-cell proliferative responses and exacerbates experimentally induced arthritis. J Clin Invest, 2001, 108: 1667-1675.
10. Beamer BA, Yen CJ, Andersen RE, et al. Association of the Prol2Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations. Diabetes, 1998, 47: 1806-1808.
11. Mancini FP, Vaccaro O, Sabatino L, et al. Prol2Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes, 1999, 48: 1466-1468.
12. Valve R, Sivenius K, Miettinen R, et al. Two polymorphisms in the peroxisome proliferator-activated receptor-γ gene are associated with severe overweight among obese women. J Clin Endocrinol Metab, 1999, 84: 3708-3712.
13. Ek J, Urhammer SA, Sorensen TIA, et al. Homozygosity of the Prol2Ala variant of the peroxisome proliferation-activated receptor-γ2 (PPAR-γ2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia, 1999, 42: 892-895.
14. Fu M, Chen H, Li XJ, et al. Association of Prol2Ala variant in peroxisome proliferator-activated receptor-γ2 gene with type 2 diabetes mellitus. Chin J Med Genet, 2002, 19: 234-237.
15. Werman A, Hollenberg A, Solanes G, et al. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPAR gamma 1 and -2 isoforms and influence of insulin. J Biol Chem, 1997, 272: 20230-202305.
16. Zhang YJ, Yang X, Chen WY, et al. Immunohistologic analysis of renal peroxisome proliferator-activated receptor γ expression in lupus nephritis patients. Chin J Rheumatol, 2006, 10: 454-456.
17. Panzer U, Schneider A, Guan Y, et al. Effects of different PPAR gamma-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis. Kidney Int, 2002, 62: 455-464.